Earnings Call · Q1 FY2023·2023-05-10

Q1 23EPS +25.00%·Rev n/aQ4 22EPS 0.00%·Rev n/aQ3 22EPS -14.29%·Rev n/aQ2 22EPS +12.50%·Rev n/a⚠ consensus missing

ADMA BIOLOGICS, INC. ADMA

Skyler Bloom — Host/Investor Relations

Adam Grossman — President and Chief Executive Officer

Brian Lenz — Executive Vice President, Chief Financial Officer

+10.9%1d on move date+11.1% vs SPY3d+17.4%5d+15.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADMA calls or request research access.

More ADMA calls Browse calls Request research access